Supervising Medical Laboratory Technologist at Zibo Central Hospital, China
Mrs. Wenxiu Tian is an accomplished Supervising Medical Laboratory Technologist at the Center of Translational Medicine, Zibo Central Hospital, with a strong academic and research background in oncology and molecular biology. Holding a Master’s degree from Shandong Second Medical University, she has demonstrated her expertise through the publication of 9 SCI-indexed papers, including multiple first-author and corresponding-author contributions. Her research focuses on the molecular mechanisms of melanoma, nasopharyngeal carcinoma, and pancreatic cancer, with particular emphasis on ferroptosis and lipid metabolism, contributing to advancements in cancer therapeutics. Mrs. Tian has also led a Shandong Provincial Medical and Health project and received the Youth Talent Award from Zibo Central Hospital in recognition of her contributions. With collaborative publications, successful project funding, and an ongoing patent application, Mrs. Tian continues to play a key role in translational cancer research, combining innovative approaches with strong scientific rigor to improve cancer diagnostics and treatment.
Professional Profile
Education
Mrs. Wenxiu Tian holds a Master’s degree in Biochemistry and Molecular Biology from Shandong Second Medical University, earned between 2019 and 2022. During her postgraduate studies, she focused extensively on molecular oncology, particularly exploring mechanisms related to cancer pathogenesis and potential therapeutic targets. Her academic training equipped her with advanced laboratory techniques, data analysis skills, and a deep understanding of cellular and molecular processes underlying cancer development. During her Master’s program, Mrs. Tian actively engaged in research, resulting in the publication of 4 SCI papers, including 2 as first author, demonstrating her ability to lead and contribute to high-impact scientific work. Her academic foundation combines strong theoretical knowledge with practical research expertise, preparing her for a successful career in translational medicine. This solid educational background has enabled her to excel in her current role at Zibo Central Hospital, where she continues to integrate academic research with clinical applications.
Professional Experience
Mrs. Wenxiu Tian has accumulated over 10 years of professional experience in the field of medical laboratory technology and translational medicine, with a focus on oncology research. She began her career in 2015 at Zibo Central Hospital, where she currently serves as a Supervising Medical Laboratory Technologist in the Center of Translational Medicine. In this role, she leads molecular biology research projects, conducts advanced laboratory diagnostics, and collaborates with clinical teams to apply research findings to patient care. Throughout her career, Mrs. Tian has demonstrated strong expertise in cancer biomarker discovery, ferroptosis mechanisms, and lipid metabolism in tumors, contributing to improved understanding of melanoma, nasopharyngeal carcinoma, and pancreatic cancer. Her work has resulted in multiple SCI publications, a provincial research project, and a patent under development. Mrs. Tian’s blend of technical laboratory skills, research leadership, and commitment to advancing cancer diagnostics and treatment makes her a valuable asset to the medical and scientific community.
Research Interest
Mrs. Wenxiu Tian’s research interests lie primarily in the field of oncology, with a particular focus on understanding the molecular mechanisms driving cancer progression and treatment resistance. Her work centers on exploring ferroptosis, a newly recognized form of programmed cell death, and its role in cancers such as melanoma, nasopharyngeal carcinoma, and pancreatic cancer. She is especially interested in the interplay between lipid metabolism and tumor microenvironments, aiming to identify novel molecular biomarkers and therapeutic targets for early diagnosis and personalized cancer treatment. Mrs. Tian also investigates the role of tumor suppressor genes, oncogenes, and signaling pathways in regulating cancer cell survival, proliferation, and metastasis. Her research integrates basic molecular biology techniques with translational applications, bridging the gap between benchside discoveries and bedside care. With an emphasis on collaborative, multi-disciplinary research, she aims to contribute to the development of more effective, targeted therapies to improve cancer outcomes.
Award and Honor
Mrs. Wenxiu Tian has received recognition and honors for her outstanding contributions to cancer research and translational medicine. One of her most notable achievements is being awarded the prestigious “Youth Talent” title by Zibo Central Hospital, acknowledging her exceptional work in molecular oncology research and her leadership in advancing innovative approaches to cancer diagnosis and treatment. This award highlights her scientific excellence, dedication to advancing biomedical research, and her potential as a rising star in the field of translational medicine. In addition to institutional recognition, Mrs. Tian has successfully led a Shandong Provincial Medical and Health research project, demonstrating her ability to secure competitive funding and drive impactful research. Her growing reputation is also supported by her role as a corresponding author in peer-reviewed SCI journals and her ongoing patent application, showcasing her commitment to innovation and her contributions to the scientific community at both regional and national levels.
Research skill
Mrs. Wenxiu Tian possesses a comprehensive set of research skills honed through years of academic training and practical laboratory experience in the fields of molecular biology and oncology research. Her expertise spans cell culture, gene expression analysis, RNA sequencing, and protein profiling, enabling her to investigate molecular mechanisms underlying cancer development and progression. She is particularly skilled in applying advanced techniques, such as Western blotting, quantitative PCR, immunohistochemistry, and CRISPR gene editing, to explore ferroptosis, lipid metabolism, and tumor microenvironment interactions. Mrs. Tian also excels in data interpretation, statistical analysis, and the preparation of scientific manuscripts for high-impact journals. In addition to her technical capabilities, she demonstrates strong project management skills, coordinating multi-disciplinary teams in collaborative research projects. Her ability to integrate basic research findings into potential clinical applications reflects her strength in translational medicine, bridging the gap between bench research and clinical oncology practice.
Conclusion
Wenxiu Tian demonstrates strong credentials for the Best Researcher Award, especially for her early-career stage. Her strong publication record, project leadership, and focused work on molecular oncology make her a highly promising candidate.
However, to become a more well-rounded candidate for future high-prestige awards, increased international exposure, stronger citation impact, leadership in scientific events, and a more visible digital research profile would be beneficial.
Publications Top Noted
-
“A Bibliometric Analysis of 3D Printing in Personalized Medicine Research from 2012 to 2022”
- Year: 2022
- Citations: Not specified in the provided data.
- DOI: Not provided.
- Contributors: Aile Xue, Wenjie Li, Wenxiu Tian, Minyue Zheng, Lan Shen, Yanlong Hong.
- Source: ResearchGate
-
“A novel nonsense variant in PLS3 causes X-linked osteoporosis in a Chinese family”
- Year: 2019
- Citations: Not specified in the provided data.
- DOI: 10.1111/ahg.12344
- Contributors: Not specified in the provided data.
- Source: ORCID
-
“Application of Doppler effect and design of Doppler effect demonstration device”
- Year: 2024
- Citations: Not specified in the provided data.
- DOI: 10.1117/12.3026485
- Contributors: Not specified in the provided data.
- Source: SPIE Digital Library
-
“Designing and deploying a mixed-reality aquarium for children with autism spectrum disorder”
- Year: 2020
- Citations: Not specified in the provided data.
- DOI: 10.1007/s11432-020-2941-7
- Contributors: Not specified in the provided data.
- Source: Springer
-
“Controllable formation of meso- and macropores within metal–organic frameworks mediated by citric acid”
- Year: 2018
- Citations: Not specified in the provided data.
- DOI: 10.1039/C8NR02896F
- Contributors: Not specified in the provided data.
- Source
